New Marketplace
Clip
Much Ado About Nothing Over Payment Reform? (05:00)

In their talks during the NEJM Catalyst event “Navigating Payment Reform for Providers, Payers, and Pharma,” both Michael McWilliams and Griffin Myers state that a certain amount of necessary payment reform might just happen on its own if we let things play out.

“Is our concern with payment reform maybe a bit of a much ado about nothing?” asks Robert Huckman during the event’s second panel discussion. “Should we let the system play its course? Or do we need to just give maybe more subtle nudges than we’re doing?”

“I believe that we’re doing too much in payment reform,” answers McWilliams. “There are too many horses out there, and we can’t have a horse race because they’re all knocking into each other.” He references the debate over bundling versus global payment as an example.

“We need to be careful about what we mean by payment reform and let a model run its course for a while to see where that takes us,” he says. “I tend to think that the global budget model, with a primary care–based risk-bearing entity, is the horse to ride and see where it takes us for a while.”

That said, the presence of disturbing trends like rapid consolidation — will any independent, risk-bearing primary care groups be left? — means that the system could use some help. “Getting the market structure right so that these payment models can really work as they should, that’s the key,” says McWilliams. He suggests the implementation of complementary policies, along with site-neutral payments and/or reforming the 340B Drug Discount Program — and reforming financial incentives that underlie the impetus for consolidation.

Myers answers Huckman’s questions from a different perspective — as someone who builds care teams rather than recommends policies. “You can’t expect policymakers to create policies for groups like Oak Street Health,” he says. “There are 60 million Medicare-eligibles; we take care of 30,000-something folks.” According to Myers, no public policy change of the past 20 years has affected Oak Street Health, with the exception of Medicare Advantage and dual integration programs.

“We’re just going to keep working along, we’re going to try to take care of as many people as we can, and do the best job we can,” Myers says. He explains that Oak Street does not make money by cutting out waste and spends the same on Medicare Part B that any other group would — but spends it differently, with savings gained from Part A. “That for us is the ultimate quality metric: people staying out of the hospital,” he says. “That’s the quality metric that happens to pay for what we do.”

He recommends that policymakers help where the majority are struggling and says he’s fine with “anything that improves the application of evidence-based, equitable, accountable care.”

From the NEJM Catalyst event Navigating Payment Reform for Providers, Payers, and Pharma, held at Harvard Business School, November 2, 2017.

More From New Marketplace
Growth in alternative payment models shared savings shared risk bundled payments population-based payments

The State of the Evidence on Payment Reform

Despite some successes among the many efforts to execute value-oriented payment models, the lack of rigorous independent research studies impedes robust progress.

University of Utah Health Buzz Survey Report Cost of Care and Physician Responsibility Out-of-Pocket Costs

Buzz Survey Report: Cost of Care and Physician Responsibility

An independent NEJM Catalyst report sponsored by University of Utah Health on how practicing clinicians and health care leaders view health care costs.

Donald Berwick Melinda Buntin Patrick Conway Raymond Vara Edward Prewitt head shots IHI forum panel on health care policy

Signal or Noise? Navigating Health Care Policy — Part 2

A discussion from the Institute for Healthcare Improvement National Forum. Part 2 of a two-part series.

Transparency Initiatives Are Maturing But Have Far to Go

New Marketplace Survey: A Slow Path to Transparency for Patients

There is national momentum to empower patients with actionable health care information. But how well is the health care industry faring with this push to improve patient-facing transparency?

Donald Berwick Melinda Buntin Patrick Conway Raymond Vara Edward Prewitt head shots IHI forum panel on health care policy

Signal or Noise? Navigating Health Care Policy — Part 1

A discussion from the Institute for Healthcare Improvement National Forum. Part 1 of a two-part series.

Union Square Family Health Evolving Clinic Schedule - after integrated practice unit changes

Leveraging IPU Principles in Primary Care

How a safety-net clinic reorganized into multidisciplinary teams and restructured clinic flow to improve both efficiency and continuity of patient care.

Goals for Health Care Price Transparency and How to Measure Its Success

Defining the Goals of Health Care Price Transparency: Not Just Shopping Around

What policymakers, providers, and payers need to do to make price transparency successful.

Liljenquist01_pullquote generic drugs

Addressing Generic-Drug Market Failures — The Case for Establishing a Nonprofit Manufacturer

A consortium of hospitals and health plans is establishing a nonprofit generic-drug manufacturer to produce a steady supply of affordable essential drugs and stimulate competition in generic-drug markets.

Shrank02_pullquote IDFS

Effective Consolidation: A Model for Reform Through Payer-Provider Integration

UPMC’s payer-provider partnership integrates real-time data to support improved clinical decision-making and optimizes clinical and financial performance.

Millenson01_pullquote big data analytics SDOH

Big Data on Social Determinants: Improved Health and Unaddressed Privacy Concerns

The use of psychographic data by health systems and health plans could provoke a backlash if not done with patient consent.

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

Topics

The State of the Evidence on…

Despite some successes among the many efforts to execute value-oriented payment models, the lack of…

Defining the Goals of Health Care…

What policymakers, providers, and payers need to do to make price transparency successful.

Value Based Care

170 Articles

The State of the Evidence on…

Despite some successes among the many efforts to execute value-oriented payment models, the lack of…

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now